Press

Press Releases

2010
3/24/2010IntelligentMDx (IMDx) Receives FDA Emergency Use Authorization (EUA) for First 2009 H1N1 Influenza Assay to be Authorized for Use on Multiple Instruments in Commercial Laboratories
2009
12/21/2009IntelligentMDx received certification to the ISO 13485:2003 Quality Management Systems standards and guidelines
12/17/2009Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics
11/2/2009Alice Jacobs, MD, founder, chair, and CEO of IntelligentMDx, talks with IVD Technology about trends and technological developments in MDx
10/3/2009Dr. Phillip Moen Named Director, Product Development at IntelligentMDx
9/22/2009Dr. Alice Jacobs describes new influenza test on Fox Business News
8/19/2009IntelligentMDx Produces Novel Flu Assay
7/21/2009IntelligentMDx to Provide Analytical and Verification Services to a Major Academic Institution
7/3/2009IntelligentMDx featured on CNBC Healthy Horizons
6/23/2009IntelligentMDx brings total financing to date to $26.5 million
6/17/2009IntelligentMDx appoints Richard Whitley, M.D. as an advisor
5/28/2009David L. Dolinger, Ph.D. has been invited to give a talk at the Q1 Productions Quality in Diagnostic Development and Manufacturing Conference
5/1/2009IntelligentMDx Completes Major Expansion at Cambridge Research Facility
4/13/2009IntelligentMDx to attend and present at 25th Annual Clinical Virology Conference
2/2/2009Sarah S. Toomey, Esq. Named Director, Intellectual Property at IntelligentMDx
1/26/2009Alice Jacobs, IntelligentMDx’s CEO, Attends the 2009 World Economic Forum in Davos, Switzerland
1/8/2009Verification Studies of IntelligentMDx’s Proprietary Molecular Diagnostic Assay Process Have Been Completed
IntelligentMDx, today announced that verification studies of the IntelligentMDx BK Viral Quantitative Assay are complete.
2008
10/29/2008Poster Presented at the Annual Association for Molecular Pathology Meeting (AMP)
10/28/2008Battelle to Perform Verification Studies of IntelligentMDx’s Proprietary Molecular Diagnostic Assay Process
IntelligentMDx a developer and manufacturer of proprietary nucleic acid assays, today announced that it is working with the Battelle Eastern Science and Technology (BEST) Center to conduct assay performance verification studies of its nucleic acid-based diagnostic or ‘smart’ molecular diagnostic assays.
6/16/2008David Dolinger Named Vice President, Research and Development
6/3/2008IntelligentMDx to Present Poster at American Society for Microbiology Regarding its HSV PCR Reagents
6/1/2008Poster Presented at the American Society of Microbiology
4/26/2008Poster Presentation to be made at Clinical Virology Symposium Detailing Results of IntelligentMDx’s HSV Real-Time PCR Reagents
4/11/2008IntelligentMDx Moves to New Corporate Headquarters and Custom Lab Facility
2/2/2008Mark Nadel Named Director of Bioinformatics and Software Development
2007
11/5/2007IntelligentMD CEO Jacobs Chairs Panel at Harvard Business School Alumni Health Industry Conference
11/2/2007Mass High Tech Features IntelligentMD in Front-Page Story
1/27/2007Alice Jacobs, IntelligentMD’s CEO, Attends the 2007 World Economic Forum in Davos, Switzerland
1/27/2007CEO of IntelligentMD Participates on Panel at World Economic Forum’s Health Governors Meeting